Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical …
M Möckel, J Searle, C Hamm, A Slagman… - European heart …, 2015 - academic.oup.com
Aims This randomized controlled trial (RCT) evaluated whether a process with single
combined testing of copeptin and troponin at admission in patients with low-to-intermediate
risk and suspected acute coronary syndrome (ACS) does not lead to a higher proportion of
major adverse cardiac events (MACE) than the current standard process (non-inferiority
design). Methods and results A total of 902 patients were randomly assigned to either
standard care or the copeptin group where patients with negative troponin and copeptin …
combined testing of copeptin and troponin at admission in patients with low-to-intermediate
risk and suspected acute coronary syndrome (ACS) does not lead to a higher proportion of
major adverse cardiac events (MACE) than the current standard process (non-inferiority
design). Methods and results A total of 902 patients were randomly assigned to either
standard care or the copeptin group where patients with negative troponin and copeptin …
